Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Immune Therapeutics, Inc. (IMUN)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | | | 0.0 | 0.5 | 0.0 | | | |
| Asset turnover | 0.0 | 0.0 | 0.0 | 1.2 | 0.0 | 0.1 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (including intangibles) | -71.0% | 10.0% | 34.8% | 36289.5% | 93.9% | 287.2% | 331.9% | -1317.5% |
| ROE | -47.8% | 7.6% | 20.7% | 36307.5% | 53.3% | 156.4% | 177.5% | -1502.9% |
| ROA | 121.0% | -8721.2% | -48797.2% | -4458148.3% | -3024.6% | -18671.0% | -25653.8% | -583.9% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | | | 0.0 | | 0.0 | 365.0 | |
| Days payables outstanding | 3,987,347.6 | | | 15.8 | | 228.1 | 162.3 | |
| Days inventory outstanding | | | | 0.6 | | | | |
| Cash conversion cycle | -3,987,347.6 | | | -15.2 | | -228.1 | 202.7 | |
|